Objective:

To evaluate the dissolution kinetics of uric acid stones at varying pH levels and saturation levels in an in vitro setting, with implications for clinical management.

Key Findings:

• Dissolution rates peaked at pH 7.2, with a sharp increase in rates above pH 6.5, indicating optimal conditions for treatment.
• Average dissolution rates for intact stones increased from 0.13 μg/dL/min at pH 6.0 to 5.98 μg/dL/min at pH 7.2, demonstrating the impact of pH on treatment efficacy.
• Ground stones showed approximately tenfold higher dissolution rates compared to intact stones, suggesting the importance of stone fragmentation.
• Lowering uric acid saturation significantly enhanced dissolution at pH 6.5 and higher, highlighting a potential therapeutic strategy.

Interpretation:

The study supports the European Association of Urology's recommendation for urine alkalinization to optimize uric acid stone dissolution, emphasizing the importance of pH over uric acid saturation and its clinical relevance.

Limitations:

• In vitro design may not replicate in vivo urinary conditions, potentially limiting the generalizability of results.
• Artificial urine model lacks urinary macromolecules and electrolyte variability, which could influence dissolution dynamics.
• Incubation times exceeded typical in vivo urine transit time, raising questions about the practical applicability of findings.

Conclusion:

Alkalinization is crucial for uric acid stone dissolution, and increasing stone surface area may aid in cases of incomplete chemolysis. Further clinical studies are needed to validate these findings and their implications for patient management.